Holen Sie sich die Stockscreener-App
1.655
2.07%
-0.035
Schlusskurs vom Vortag:
$1.69
Offen:
$1.72
24-Stunden-Volumen:
134.92K
Relative Volume:
0.06
Marktkapitalisierung:
$155.16M
Einnahmen:
$34.48M
Nettoeinkommen (Verlust:
$-102.07M
KGV:
-1.1336
EPS:
-1.46
Netto-Cashflow:
$-104.90M
1W Leistung:
+4.09%
1M Leistung:
-11.50%
6M Leistung:
-5.43%
1J Leistung:
-3.78%
1-Tages-Spanne:
$1.65
$1.7299
1-Wochen-Bereich:
$1.54
$1.80
52-Wochen-Spanne:
$0.66
$3.535
Caribou Biosciences Inc Stock (CRBU) Company Profile
Firmenname
Caribou Biosciences Inc
Sektor
Branche
Telefon
510-982-6030
Adresse
2929 7TH STREET, SUITE 105, BERKELEY
Vergleichen Sie CRBU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.66 | 157.96M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.36 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
811.17 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
407.74 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
811.36 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.32 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-11-08 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-10-31 | Eingeleitet | Evercore ISI | Outperform |
| 2023-07-11 | Eingeleitet | Truist | Buy |
| 2022-02-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-12-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-17 | Eingeleitet | BofA Securities | Buy |
| 2021-08-17 | Eingeleitet | Citigroup | Neutral |
| 2021-08-17 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Caribou Biosciences Inc Aktie (CRBU) Neueste Nachrichten
Why Caribou Biosciences Inc. stock is rated strong buy2025 Market Sentiment & Growth Focused Stock Reports - ulpravda.ru
Will Caribou Biosciences Inc. stock benefit from automationStop Loss & Weekly Breakout Opportunity Watchlist - ulpravda.ru
How sustainable is Caribou Biosciences Inc. stock dividend payoutShort Interest Overview & Superior Growth Investment - bollywoodhelpline.com
How Caribou Biosciences Inc. stock trades before earningsPortfolio Return Report & AI Based Trade Execution Alerts - ulpravda.ru
Can Caribou Biosciences Inc. stock sustain revenue growthM&A Rumor & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Income Plays: How analysts rate Caribou Biosciences Inc. stock todayMarket Risk Summary & High Conviction Buy Zone Picks - ulpravda.ru
What is the fair value of Caribou Biosciences Inc. stock nowGeopolitical Risk Analysis & Missed Nvidia? Don’t Miss This One - ulpravda.ru
Can Caribou Biosciences Inc. stock continue upward trendMean Reversion Trades & Big Gains Low Budget - ulpravda.ru
Aug Intraday: Can Caribou Biosciences Inc stock sustain revenue growthMarket Weekly Review & Daily Volume Surge Trade Alerts - moha.gov.vn
Caribou Biosciences (CRBU) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will Caribou Biosciences Inc stock remain a Wall Street favoriteGold Moves & Low Risk Entry Point Guides - moha.gov.vn
What valuation multiples suggest for Caribou Biosciences Inc. stockGap Fill Strategies & Affordable Growth Investments - bollywoodhelpline.com
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge - GlobeNewswire
Caribou Biosciences (NASDAQ:CRBU) Trading Up 2.4%Should You Buy? - MarketBeat
Why Caribou Biosciences Inc. stock is popular among millennialsJuly 2025 News Drivers & Weekly Momentum Picks - Улправда
Would You Still Hold Caribou Biosciences Stock If It Fell Another 30%? - Trefis
How analysts rate Caribou Biosciences Inc. stock today2025 Short Interest & Accurate Entry and Exit Point Alerts - DonanımHaber
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com
Published on: 2025-12-19 16:09:33 - Улправда
Can Caribou Biosciences Inc. stock sustain institutional interestJuly 2025 Setups & Smart Swing Trading Alerts - DonanımHaber
How risky is Caribou Biosciences Inc. stock nowQuarterly Market Review & Free High Accuracy Swing Entry Alerts - DonanımHaber
Wall Street Recap: Why hedge funds are buying Caribou Biosciences Inc. stock2025 Historical Comparison & Consistent Profit Trading Strategies - Улправда
Targets Report: How sustainable is Caribou Biosciences Inc. stock dividend payoutWeekly Trade Report & Real-Time Volume Trigger Notifications - Улправда
Will Caribou Biosciences Inc. stock remain a Wall Street favoriteM&A Rumor & Reliable Entry Point Alerts - Улправда
Published on: 2025-12-19 08:19:09 - Улправда
Published on: 2025-12-19 00:46:22 - Улправда
What analyst consensus says on Caribou Biosciences Inc. stockJuly 2025 Action & High Accuracy Buy Signal Tips - Улправда
Market Overview: Why Caribou Biosciences Inc. stock is a value investor pickJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - Улправда
Chart Watch: How risky is Caribou Biosciences Inc stock nowWeekly Trade Review & AI Enhanced Trading Alerts - moha.gov.vn
Caribou Biosciences Earnings Notes - Trefis
Published on: 2025-12-14 05:29:10 - earlytimes.in
Bank of America Securities Sticks to Their Buy Rating for Caribou Biosciences (CRBU) - The Globe and Mail
Will Caribou Biosciences Inc. stock reach Wall Street targets2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Caribou Biosciences Target of Unusually Large Options Trading (NASDAQ:CRBU) - MarketBeat
Caribou Biosciences to Host Expert Panel on Access Expansion for vispa-cel CAR-T Therapy at ASH Annual Meeting - Quiver Quantitative
Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025 - 富途牛牛
MACD Signal: Will ABEV stock outperform value stocksJuly 2025 Earnings & Accurate Intraday Trading Signals - BỘ NỘI VỤ
Earnings Risk: What analyst consensus says on Caribou Biosciences Inc stockJuly 2025 Pullbacks & Free Daily Entry Point Trade Alerts - BỘ NỘI VỤ
Caribou Biosciences CEO to address Evercore Healthcare Conference - Traders Union
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Caribou Biosciences, Inc. $CRBU Shares Bought by Envestnet Asset Management Inc. - MarketBeat
Caribou Biosciences signals access challenge in CAR-T cell therapy - Traders Union
Analyzing Caribou Biosciences Inc. with multi timeframe chartsJuly 2025 WrapUp & Accurate Trade Setup Notifications - newser.com
Is Caribou Biosciences Inc. stock positioned well for digital economyJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
Finanzdaten der Caribou Biosciences Inc-Aktie (CRBU)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):